Human Papillomavirus awareness and vaccine acceptability among men who have sex with men from mainland China

Xiangwei Li, Xuefang Cao, Zhen Li, Yu Yang, Mufei Li, Boxuan Feng, Henan Xin, Haoran Zhang, Lei GaoScientific 2019 · DOI

Abstract

Reductions in persistent Human Papillomavirus (HPV) infection and related diseases have been well-documented among vaccinated males. However, awareness remains low in high-risk subgroups such as men who have sex with men (MSM) in China. This multicenter cross-sectional study of 3,057 MSM across 10 Chinese cities found that only 20.6% had baseline awareness of HPV. Following a targeted educational intervention, vaccination acceptability rose to 97.8%. Despite high willingness, significant price sensitivity exists, with only 2.5% willing to pay more than 2000 RMB. These findings underscore the urgent need for tailored public health education and economic subsidies to improve HPV vaccine uptake in this population.

Introduction

While HPV is frequently associated with cervical cancer, it is also a primary driver of anal and penile cancers, as well as genital warts in men. MSM face a disproportionately high risk for these pathologies, particularly when co-infected with HIV. Although the quadrivalent HPV vaccine has been available for males globally since 2009, public health initiatives in China have historically prioritized females. This study addresses the critical knowledge gap regarding HPV awareness and vaccine acceptability among Chinese MSM.

Methods

The researchers conducted a multicenter cross-sectional study across 10 cities in mainland China, categorized by economic development (Developed, Medium, and Less Developed).

  • Participants: 3,057 MSM were recruited via NGOs, social media, and peer referrals.
  • Procedure: Participants completed a baseline questionnaire on demographics and HPV knowledge, followed by a "knowledge lecture" regarding HPV risks and vaccine benefits.
  • Evaluation: A post-test measured changes in vaccination willingness and "willingness-to-pay" (WTP) using interval regression models to estimate economic thresholds.

Key Results

The Awareness Gap and Information Channels

Baseline awareness was remarkably low: only 20.6% of participants had heard of HPV, and a mere 4.8% were aware of the HPV vaccine. This contrasts sharply with Western cohorts where awareness often exceeds 70%. The study identified a clear preference for digital information delivery; while many currently receive information through various channels, the internet is the most desired source for future knowledge.

Comparison of current and preferred sources for HPV knowledge among participants.

Acceptability and Economic Barriers

The educational intervention proved highly effective, with vaccination willingness jumping to 97.8% post-lecture. This suggests that the primary barrier to vaccination is a lack of information rather than inherent hesitancy. However, economic factors remain a significant hurdle. The study revealed a sharp decline in willingness as the price of the vaccine increased.

Willingness to pay for HPV vaccination relative to price points (RMB).

Key motivators for vaccination included general health consciousness (75.1%) and confidence in vaccine efficacy (44.1%). Conversely, the primary concerns were vaccine safety (54.2%) and the perceived severity of HPV infection (52.3%).

Discussion and Policy Implications

The study demonstrates that Chinese MSM are highly receptive to HPV vaccination once informed of its benefits. However, the current market price of the vaccine exceeds the WTP for the vast majority of this population. To achieve effective public health outcomes, the authors recommend:

  1. Enhanced Education: Utilizing internet-based platforms to deliver targeted health information to the MSM community.
  2. Economic Subsidies: Implementing government subsidies to align vaccine costs with the population's WTP (ideally below 500 RMB).
  3. Clinical Expansion: Accelerating clinical trials for males in China to facilitate formal approval and integration into national immunization programs.

While the study is limited by potential selection bias from NGO-based recruitment, it provides a robust foundation for future public health strategies targeting high-risk male populations in China.

Summary updated

Abstract

Reductions in persistent HPV infection and related diseases occurrence have been proved among vaccinated males. However, little was known on awareness of HPV and the vaccine in males, especially in high-risk subgroups such as men who have sex with men (MSM), in China. A multicenter cross-sectional study was conducted in MSM from 10 selected cities in mainland China. HPV awareness and vaccination acceptability were investigated through interviews and questionnaires. In total, 3057 eligible participants aged 18 years older from 10 cities were investigated. Only 20.6% (629/3057) of them had ever heard of HPV and 4.8% (146/3057) had heard of HPV vaccine. Factors that potentially influence willingness for HPV vaccination were found to be safety of the vaccine (54.2%, 1656/3057) and severity of HPV infection (52.3%, 1599/3057). After education, 97.8% (2882/2946) of participants would like to pay for HPV vaccination, and only a minority of them (2.5%, 75/2946) would like to afford more than 2000 RMB. Our results showed that the awareness on HPV and the vaccine were quite poor among MSM in mainland China. To promote the application of HPV vaccination in male populations, appropriate information delivery and education on HPV infection and health should be enhanced as well as in females.
BibTeX
@inproceedings{li2019human,
  author = {Xiangwei Li and Xuefang Cao and Zhen Li and Yu Yang and Mufei Li and Boxuan Feng and Henan Xin and Haoran Zhang and Lei Gao},
  title = {{Human Papillomavirus awareness and vaccine acceptability among men who have sex with men from mainland China}},
  booktitle = {Scientific},
  year = {2019},
  doi = {10.1038/s41598-019-45258-0},
}
Figure